TrialJournal of neuro-oncology2023

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.

J Weller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.